India, April 2 -- Rx Propellant, India's premier life sciences infrastructure platform backed by Actis, has unveiled 1GV, a cutting-edge 136,000 sq. ft. research and innovation campus built over 1.8 acres in Genome Valley, Hyderabad. This launch marks another milestone in Rx Propellant's unwavering commitment to advancing India's life sciences ecosystem and shaping its future.

The story of 1GV is deeply intertwined with the origins of Genome Valley, one of Asia's largest life sciences clusters. This site, long before it became 1GV, was where the first brick was laid, setting the foundation for the region's remarkable growth.

Over the years, this campus has been instrumental in scientific breakthroughs, witnessing and contributing to the...